Cardiac complications are the main cause of morbidity and mortality related with HBP in our setting and entail first magnitude human and social-health care consequences. Although the incidence of ACVA has decreased in recent decades, this has not occurred with the same intensity for cardiac complications, probably due to their multifactorial origin. Left ventricular hypertrophy, main etiologic responsible factor of hypertensive heart disease that includes heart failure, ischemic heart disease, arrhythmias and sudden death are found as nuclear element of the cardiac disease. Consequently, the magnitude, etiological diversity, vulnerability and social-health care implications grant the intervention on cardiac protection a priority role in the management of HBP and its complications.